Skip to main content
NeopharmCO.,LTD. logo

NeopharmCO.,LTD. — Investor Relations & Filings

Ticker · 092730 ISIN · KR7092730001 KO Manufacturing
Open in API
Filings indexed 205 across all filing types
Latest filing 2025-05-09 Earnings Release
Country KR South Korea
Listing KO 092730

About NeopharmCO.,LTD.

https://neopharm.co.kr

Neopharm is a science-based company specializing in the development, manufacturing, and sale of dermatological skincare and cosmetic products. A pioneer in skin barrier research, the company focuses on restoring skin homeostasis. Its core innovation is the proprietary Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin to repair and strengthen its protective functions. The company's primary product lines, including the flagship brand Atopalm, are specifically formulated for sensitive, dry, and compromised skin. These non-steroid solutions are grounded in dermatological science to address various skin concerns.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (잠정실적) for Neopharm, detailing quarterly financial performance (revenue, operating profit, net income) for the period ending March 31, 2025. It provides key financial highlights and is clearly an initial announcement of quarterly results rather than a full interim report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). Q1 2025
2025-05-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과) for the company NeoPharm. It details the approval of financial statements, dividend resolutions, and the appointment of directors and audit committee members. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the outcomes of shareholder votes at the AGM.
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of outside directors (사외이사의 선임). This falls under the category of board and management changes, specifically the appointment of new board members.
2025-03-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives), which corresponds to the 'Director's Dealing' category.
2025-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (It's Hanbul) in the issuer (Neopharm) due to the resignation of a special related party (director). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean DART system titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, revenue, profit), and details regarding the external auditor. While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full 10-K annual report itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2024
2025-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.